OrienX010, an oncolytic virus, in patients with unresectable stage IIIC-IV melanoma: a phase Ib study.
Cui C, Wang X, Lian B, Ji Q, Zhou L, Chi Z, Si L, Sheng X, Kong Y, Yu J, Li S, Mao L, Tang B, Dai J, Yan X, Bai X, Andtbacka R, Guo J.
Cui C, et al. Among authors: yu j.
J Immunother Cancer. 2022 Apr;10(4):e004307. doi: 10.1136/jitc-2021-004307.
J Immunother Cancer. 2022.
PMID: 35383116
Free PMC article.
Clinical Trial.